The Brain Research and Interventional Neurotherapeutics (BRAIN) Program at Butler Hospital involves a combination of research and clinical treatments within interventional psychiatry that focuses on advanced treatments for mental health disorders for individuals who do not respond to traditional therapies like medication and psychotherapy.
This subspeciality within psychiatry includes treatments such as Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Esketamine (Spravato), neurofeedback, self-neuromodulation, and new cutting-edge modalities for major depressive disorder, obsessive compulsive disorder, post traumatic stress disorder, addiction, bipolar disorder, and other Neuropsychiatric disorders.
This unique program is integrated with scientific research to help develop personalized treatment approaches, target patient-specific symptoms, and identify potential biomarkers to predict clinical response and optimize outcomes.
Butler Hospital
345 Blackstone Boulevard
Providence, RI 02906
You may click on the individual programs below to learn more information about those treatments and what steps to take to begin the screening process with our team. For general questions, please call 1 (844) 401- 0111 to Butler Hospital’s intake department.
According to the American Psychiatric Association, ECT is considered the most effective treatment for major depression for people who have not found relief of their symptoms from medications or other forms of therapy.
Esketamine, marketed as Spravato, is the first FDA- approved treatment version of a drug commonly known as “ketamine” for adults struggling with major depressive disorder. It is used as a self-administered nasal spray and delivered under the supervision of trained professionals.
Transcranial Magnetic Stimulation (TMS) is a revolutionary treatment, approved by the FDA, for patients suffering from depression and obsessive-compulsive disorder (OCD) who have not responded to standard medications and therapy.
Linda L. Carpenter, MD is a Professor of Psychiatry in the Alpert Medical School of Brown University and Chief of the Mood Disorders Program at Butler Hospital. She completed her undergraduate degree at the University of Michigan and medical school at the University of Pennsylvania. She did an internship in internal medicine, psychiatry residency, and research fellowship at Yale, and then joined the faculty of the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University in 1997.
She has continued her path since then as a physician-researcher investigating the neurobiology of, and new treatments for, major depression and other mood and anxiety disorders. Dr. Carpenter has also conducted a number of randomized clinical trials sponsored by industry and NIH, investigating investigational drugs and devices for treating depression, including esketamine, Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), Transcranial Magnetic Stimulation (TMS) and transcranial Direct Current Stimulation (tDCS). She is the founding Director of the Butler Hospital TMS Clinic and Neuromodulation Research Facility and co-author of several published TMS Clinical practice guidelines. Dr. Carpenter was engaged in TMS research prior to the first FDA clearance in 2008, and has remained active as a TMS clinician and researcher since then. She is a faculty member of several national TMS training courses and has served in various leadership roles for the Clinical TMS Society. She is a member of the American Psychiatric Association (APA) Council on Research, past President of the Society of Biological Psychiatry (SOBP), and has published extensively on TMS and other treatments for depression.
Mr. Eric Tirrell completed his undergraduate degree in psychology at the University of Rhode Island. He is the TMS and Esketamine clinical supervisor of Butler Hospital’s TMS Clinic and has been providing TMS treatment for neuropsychiatric disorders for over 8 years. He has extensive experience with all aspects of TMS clinical care and he is well versed in operating Neurostar, Magstim, Nexstim, MagnMore, Magventure and other investigational TMS device systems using a variety of TMS protocols and coils.
In addition to his role on the TMS and Esketamine clinical service, Eric also serves as the Research Coordinator for Butler’s Neuromodulation Research Facility and has led a wide range of studies in individuals across the lifespan. He works with Butler Hospital and Brown University-based faculty within the Department of Psychiatry and Human Behavior and their research staff in Butler’s COBRE Center for Neuromodulation to incorporate noninvasive brain stimulation and imaging techniques into their clinical research. He has had extensive training in the collection of physiological data and brain imaging for biomarker development and investigating brain network function and connectivity. His goals are to help develop optimized individual neuromodulation approaches for depression and to ultimately use TMS as a treatment modality for a wide range of conditions and disorders.
Dr. Audrey Tyrka is Mary E. Zucker Professor and Chair, of the Department of Psychiatry and Human Behavior. She received her MD and PhD in medicine and psychology through a combined program at the University of Pennsylvania in 1999. Dr. Tyrka completed psychiatry residency training at Brown and further research training in clinical neuroscience at the Mood Disorders Research Program and Laboratory for Clinical Neuroscience at Butler Hospital.
Dr. Tyrka is Co-Director of the Center for Stress, Trauma, and Resilience (STAR), which includes the STAR COBRE Center and a STAR Research Postdoctoral Fellowship T32 program. Internationally known for her groundbreaking work on early adversity, Dr. Tyrka has made discoveries of neuroendocrine, epigenetic, and biological aging processes that are now widely understood to underlie stress-associated mental and physical health conditions. She has also contributed to pharmacologic, behavioral, and neuromodulation treatments trials for depression and is an attending psychiatrist in the Butler Hospital Transcranial Magnetic Stimulation and Esketamine Clinic. A dedicated mentor and leader in research training, Dr. Tyrka is PI of Brown Universities NIMH-funded R25 Research Training Program for physician scientists in psychiatry training. The Department of Psychiatry and Human Behavior is committed to measurable policies and practices that foster diversity, equity, inclusion and belonging, and promote anti-racism within our education, research, and clinical care settings and the community at large. A member of the Community Advisory Board of Sojourner House, Dr. Tyrka is also a painter and mixed-media artist, and she contributes the proceeds from her art toward their mission to support people affected by domestic and sexual violence.
Dr. Benjamin Greenberg has a BA in psychology from Amherst College, a PhD in neurosciences from UC San Diego, and an MD from the University of Miami, with psychiatry residency at Johns Hopkins. He then led adult OCD research at NIMH, where he performed the first transcranial magnetic stimulation (TMS) study in that illness. At Butler Hospital and Brown since 2000, he has focused on invasive neurosurgeries including ventral capsulotomy and deep brain stimulation (DBS).
FDA humanitarian approval of DBS for intractable OCD in 2009 was based on that work. His NIH funding has included R21, R01, U01, P50, and P20 grants. He has a secondary focus in psychiatric genetics. As a clinical psychiatrist, he has treated OCD for thirty years; and over the past five years has also treated PTSD, he previously led Butler outpatient services. He currently directs the COBRE Center for Neuromodulation at Butler Hospital and co-directs the Center for Neuromodulation and Neurotechnology (CfNN) at the Providence VAMC (PVAMC), in both roles focusing on noninvasive brain stimulation.
Dr. Alvaro Olivares graduated from the Universidad del Norte Faculty of Medicine in Barranquilla, Colombia and completed his residency at Butler Hospital. He is a board-certified psychiatrist who serves as the unit chief in psychiatry at Butler Hospital and hosts a weekly Spanish radio program, “Mental Health with Dr. Olivares.” Dr. Olivares conducts assessments in Spanish for the program’s A4 study. He currently serves as the chief of the Kent inpatient Unit at Butler and the Chief of the Outpatient ECT department.
Dr. Lawrence Price attended the University of Michigan, where he received a B.S. with highest honors in psychology and high distinction in 1974, followed by an M.D. in 1978. After an internship in internal medicine at Norwalk Hospital, he completed a residency and fellowship in psychiatry at Yale University. From 1982 until 1996, Dr. Price was on the faculty in the Department of Psychiatry at Yale University, where he served as Associate Professor and Director of the Clinical Neuroscience Research Unit at the Connecticut Mental Health Center.
Since 1996, he has been Professor of Psychiatry at Brown University. From 1996 to 2012, he was Clinical Director, Director of Research, and Chair of the Institutional Review Board at Butler Hospital in Providence, Rhode Island, subsequently serving as Chief Medical Officer from 2012 until 2014. He was President of Butler Hospital and Executive Chief of the Brain and Behavioral Health Service Line of Care New England from 2014 until 2017. He was identified by the Institute for Scientific Information as one of the top ten authors of high-impact papers in psychiatry from 1990 to 1999. In addition to his research activities, Dr. Price has received numerous awards for his teaching and clinical work, and is Editor of the Brown University Psychopharmacology Update and Editor (with I. Stolerman) of the Encyclopedia of Psychopharmacology, Second Edition.
Dr. Brian Tesar received a B.A. with honors in Chemistry from the University of Chicago in 1987. He studied medicine and biochemistry and received his M.D. from the University of Illinois in 1992. Dr. Tesar completed a psychiatric residency program with Washington University in St. Louis in 1996.
After completing his training, Dr. Tesar cared for patients in a variety of roles: as staff psychiatrist and day hospital medical director at the Cape Cod and Islands Community Mental Health Center(1996-2000), as medical director of Gosnold on Cape Cod outpatient clinics(2000-2004), as staff psychiatrist for AHRC New York(2005-2009), and as medical director of the Kent Hospital (Warwick, RI) psychiatric care unit (2009-2017). Since 2017, Dr. Tesar has served as staff psychiatrist at Butler Hospital (Providence, RI) in both the inpatient and partial hospital programs. Dr. Tesar is also a self-taught computer programmer whose experience includes development of a database system and dynamically driven website for a real estate company in New York City. Dr. Tesar has a strong interest in developing computer systems that enhance psychiatric care.
Dr. Fatih Kokdere received his medical degree from Yeditepe University located in his hometown Istanbul, Turkey. Following his graduation, he joined Butler Hospital’s TMS Clinic and Neuromodulation Research Facility as a postdoctoral research fellow. He completed his psychiatry residency at MercyOne Des Moines Medical Center in Iowa and returned to Butler Hospital as an attending psychiatrist in our program in addition to assessing patients in the Inpatient Assessment Center.
Copyright © 2023 Care New England Health System